Congress Set To Pass Six-Month Funding Bill, As Sequestration Still Looms
This article was originally published in The Gray Sheet
Executive Summary
Both the pending continuing resolution legislation and the sequestration have potential implications, not only for the funding FDA receives from Congress, but also for contributions from industry user fees.